Syneos Health Inc (SYNH)

94.11 +0.37  +0.39% NASDAQ Sep 17, 10:08 USD
View Full Chart
Price Chart
View All SYNH News

News

View All Events

Events

Date Type Description
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
08/09/2021 Earnings Results Q2 2021 Earnings Results
08/09/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
05/12/2021 08:00 EST AGM 2020 Annual General Meeting
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
02/18/2021 Earnings Results Q4 2020 Earnings Results
02/18/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company’s commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
  • URL: https://www.syneoshealth.com
  • Investor Relations URL: https://www.investor.syneoshealth.com/
  • HQ State/Province: North Carolina
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Oct. 29, 2021
  • Last Earnings Release: Aug. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
FSCRX Fidelity® Small Cap Discovery 2.80%
LCBSX ClearBridge Select FI 2.22%
LMPMX ClearBridge Small Cap Growth 1 2.17%
RFG Invesco S&P MidCap 400® Pure Growth ETF 1.71%
JSEQX JPMorgan Small Cap Equity R4 1.47%
NDVRX MFS New Discovery Value R1 1.38%
HQL Tekla Life Sciences Investors 1.37%
HQH Tekla Healthcare Investors 1.23%
VASVX Vanguard Selected Value Inv 1.21%
IJK iShares S&P Mid-Cap 400 Growth ETF 0.85%
MDYG SPDR® S&P 400 Mid Cap Growth ETF 0.85%
IVOG Vanguard S&P Mid-Cap 400 Growth ETF 0.84%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.